EMPLOYMENT AGREEMENTEmployment Agreement • March 30th, 2015 • Scynexis Inc • Pharmaceutical preparations
THIS EMPLOYMENT AGREEMENT ("Agreement"), effective as of February 5, 2015 (the "Effective Date"), is by and between SCYNEXIS, Inc., a Delaware corporation ("Employer" or "Company") and Marco Taglietti, MD ("Employee").
EXCLUSIVE LICENSE AGREEMENT BETWEEN WATERSTONE PHARMACEUTICAL (HK) LIMITED AND SCYNEXIS, INC. DATED AS OF October 29, 2014Exclusive License Agreement • March 30th, 2015 • Scynexis Inc • Pharmaceutical preparations • New York
THIS EXCLUSIVE LICENSE AGREEMENT (this “Agreement”), dated as of October 29, 2014, is entered into by and between Waterstone Pharmaceutical (HK) Limited, a company organized and existing under the laws of Hong Kong SAR, having offices located at Suite 3201, Tower Two, Lippo Centre, 89 Queensway, Admiralty, Hong Kong (“Waterstone”), and SCYNEXIS, Inc., a corporation organized and existing under the laws of the State of Delaware, having offices located at 3501C Tricenter Boulevard, Durham North Carolina, USA 27713 (“Scynexis”).
RESEARCH SERVICES AGREEMENTResearch Services Agreement • March 30th, 2015 • Scynexis Inc • Pharmaceutical preparations
This Research Services Agreement (this “Agreement”) is dated as of December 24, 2014 (the “Effective Date”), and is by and between MERIAL INC., a Georgia company having a place of business at 3239 Satellite Boulevard, Bldg. 500, Duluth, Georgia 30096 USA, on behalf of itself and any of its subsidiaries and/or Affiliates (hereinafter, “MERIAL”), and SCYNEXIS, INC., a Delaware corporation having a place of business at 3501 C Tricenter Boulevard, Durham, NC 27713 (hereinafter, “SCYNEXIS”).
